Well Lead Med Co Ltd (603309) - Total Liabilities
Based on the latest financial reports, Well Lead Med Co Ltd (603309) has total liabilities worth CN¥960.53 Million CNY (≈ $140.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Well Lead Med Co Ltd generate cash to assess how effectively this company generates cash.
Well Lead Med Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Well Lead Med Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Well Lead Med Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Well Lead Med Co Ltd Competitors by Total Liabilities
The table below lists competitors of Well Lead Med Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Qingdao Citymedia Co Ltd
SHG:600229
|
China | CN¥1.04 Billion |
|
Fireweed Zinc Ltd
V:FWZ
|
Canada | CA$15.54 Million |
|
Gazit Globe Ltd
TA:GZT
|
Israel | ILA27.40 Billion |
|
Inner Mongolia North Hauler Joint Stock Co Ltd
SHG:600262
|
China | CN¥3.27 Billion |
|
RaySearch Laboratories AB (publ)
ST:RAY-B
|
Sweden | Skr1.02 Billion |
|
Natural Grocers by Vitamin Cottage Inc
NYSE:NGVC
|
USA | $448.55 Million |
|
Shinkong Textile Co Ltd
TW:1419
|
Taiwan | NT$7.46 Billion |
|
Shandong Rike Chemical
SHE:300214
|
China | CN¥2.43 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Well Lead Med Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Well Lead Med Co Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Well Lead Med Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Well Lead Med Co Ltd (2011–2024)
The table below shows the annual total liabilities of Well Lead Med Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥937.61 Million ≈ $137.20 Million |
+22.03% |
| 2023-12-31 | CN¥768.37 Million ≈ $112.44 Million |
+19.34% |
| 2022-12-31 | CN¥643.85 Million ≈ $94.22 Million |
+19.04% |
| 2021-12-31 | CN¥540.87 Million ≈ $79.15 Million |
+56.85% |
| 2020-12-31 | CN¥344.83 Million ≈ $50.46 Million |
-17.77% |
| 2019-12-31 | CN¥419.35 Million ≈ $61.36 Million |
-11.61% |
| 2018-12-31 | CN¥474.41 Million ≈ $69.42 Million |
+328.82% |
| 2017-12-31 | CN¥110.63 Million ≈ $16.19 Million |
+1.15% |
| 2016-12-31 | CN¥109.37 Million ≈ $16.00 Million |
+6.78% |
| 2015-12-31 | CN¥102.43 Million ≈ $14.99 Million |
-34.18% |
| 2014-12-31 | CN¥155.62 Million ≈ $22.77 Million |
-9.07% |
| 2013-12-31 | CN¥171.15 Million ≈ $25.04 Million |
+7.12% |
| 2012-12-31 | CN¥159.77 Million ≈ $23.38 Million |
-7.05% |
| 2011-12-31 | CN¥171.89 Million ≈ $25.15 Million |
-- |
About Well Lead Med Co Ltd
Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guid… Read more